"10.1371_journal.pone.0044481","plos one","2012-11-07T00:00:00Z","Jennifer C Irvine; Virat Ganthavee; Jane E Love; Amy E Alexander; John D Horowitz; Johannes-Peter Stasch; Barbara K Kemp-Harper; Rebecca H Ritchie","Heart Failure Pharmacology, Baker IDI Heart & Diabetes Institute, Melbourne, Victoria, Australia; Department of Pharmacology, Monash University, Clayton, Victoria, Australia; Department of Medicine, Monash University, Clayton, Victoria, Australia; Cardiology Unit, The Queen Elizabeth Hospital, Woodville South, South Australia, Australia; Pharma Research Center, Bayer Schering Pharma AG, Wuppertal, Germany","Conceived and designed the experiments: RHR JCI VG BKK. Performed the experiments: JCI VG RHR BKK AEA JEL. Analyzed the data: JCI RHR VG AEA JEL. Contributed reagents/materials/analysis tools: JPS. Wrote the paper: RHR BKK JCI. Reviewed/edited the manuscript: JDH JPS.","The authors have read the journals policy and declare the following conflict: Johannes-Peter Stasch is currently a full-time employee of Bayer Schering Pharma AG, Germany. Bayer Schering has not funded the research, nor have they had a role in study design, data collection or analysis. BAY 41-2272 and BAY 58-2667 were provided by Bayer Schering Pharma AG (Germany) for this study, and are Bayer products. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","11","Jennifer C Irvine","JCI",8,TRUE,4,6,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
